联邦制药国际控股有限公司（股票代码：03933）于2026年3月4日发布的月报显示，截至2026年2月28日，公司注册股本维持3,800,000,000股，面值每股0.01港元，对应注册股本总额为38,000,000港元，较上月无任何增减变化。
公司已发行股份总数为1,973,026,508股，库存股份为零，报告期内不存在新增发行、购回或注销股份等活动。公司同时确认已符合香港联交所适用的公众持股量要求，并遵守相关上市规则及法律法规。
公告由公司秘书梁永康正式签署，公司股本结构及上市地位均保持稳定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.